IRDOpus Genetics, Inc.

$349M

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$6M

Net Income

-$6M

EPS (Diluted)

$-0.35

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$6M

Stock-Based Comp.

$479,000

Balance Sheet

Total Assets

$26M

Total Liabilities

$4M

Stockholders' Equity

$22M

Cash & Equivalents

$25M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$6M	-$14M	+56.1%
Net Income	-$6M	-$19M	+66.2%

IRD Q4 2021 Earnings — Opus Genetics, Inc. Revenue & Financial Results | Market Cap Arena